Shareholder Information

Key Shareholder Information

Corporate Presentation

An overview of the most recent information about MDxHealth can be found in the company’s periodic corporate presentation slides. The latest MDxHealth Corporate Presentation can be downloaded here.

Corporate Governance Charter

MDxHealth attaches great value to corporate governance practices.
On September 7, 2011, our board of directors approved the current version of MDxHealth’s Corporate Governance Charter. The Charter has been drafted in accordance with the principles and the provisions of the Belgian Corporate Governance Code 2009 issued on March 12, 2009 by the Corporate Governance Committee.

The full text of MDxHealth’s Corporate Governance Charter can be downloaded here.

Dealing Code

As a listed company, MDxHealth must comply with rules governing insider trading. The company's dealing code can be found here.

Articles of Association

The Articles of Association are periodically updated. The latest version (July 4, 2012) can be found here:

English version

Version Française

Share capital history

The history of the share capital issuance since the inception of the company can be found here:

History of share capital since incorporation

Transparency Declarations of the largest shareholders

Shareholders holding more than 3% of the company’s outstanding shares have provided the company with the notifications of their shareholding. The most recent notifications are here:

Summary of received transparency notifications

History of transparency notifications

Notification Required by Shareholders holding more than 3% of the Outstanding Shares

Summary of transparency declarations received as per July 5, 2012

History of transparency declarations received as per July 5,2012

Each natural or legal person acquiring or transferring MDxHealth’s shares is required to notify MDxHealth and the Financial Services and Markets Authority (FSMA) each time their shareholding crosses a threshold of three percent (3%) of the total number of outstanding shares (the denominator). Such notification is also required each time, as a result of an acquisition or transfer a threshold of five percent (5%) and a multiple of five percent (5%) is crossed. Complete information regarding this requirement is found in Article 14 of MDxHealth’s articles of association.

The transparency notifications should be reported within 5 business days of crossing the threshold by following the procedures outlined on the FSMA website found here.

A copy of the transparency notification should also be emailed and faxed to the company, to the attention of: Francis Ota, CFO, at This e-mail address is being protected from spambots. You need JavaScript enabled to view it and fax +32 4 364 20 84.

Annual and Extraordinary Shareholders' Meetings

The annual general shareholders’ meeting is held at the registered office or at the place determined in the notice convening the shareholders’ meeting. The meeting is held every year on the last Friday of May at 10 a.m. The notice and agenda, as well as a model of power of attorney are made available here at least 30 calendar days prior to the annual shareholders' meeting.

Next Shareholder's Meeting Material

• Notice/invitation/agenda for the Annual and Extraordinary Shareholders' meetings  Convening notice English - Convocation Français
• Proxy form for the Annual and Extraordinary Shareholders' meetings   Proxy - Procuration

Recent Shareholder's Meetings

Analyst Coverage

Please note that any opinions, estimates or forecasts made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of MDxHealth or its management. Requests for copies of analyst reports should be directed at the respective analyst and institution.

Paying Agent

The financial service for the shares of the company is provided in Belgium by ING and Fortis Bank. In the Netherlands, the financial service is provided by Fortis Bank. Shareholders should inform themselves about the c osts that other financial intermediaries may charge in connection with paying agency services.

Special Reports of the Board and Auditor (in French language only)

View reports

Listing prospectus - April 2013

View reports

Listing prospectus - July 2012

View reports

Listing prospectus - April 2011

View reports